Ratings by Citi (Navann Ty)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/10/2022 | Viatris | VTRS | Maintain | Neutral (N/A) |
|
Details | ||
| 12/1/2021 | Alkermes | ALKS | New Coverage | Neutral (N/A) |
21.92 (48.00) |
118.98% | Details | |
| 10/5/2021 | Jazz Pharmaceuticals | JAZZ | New Coverage | Buy (N/A) |
127.21 (248.67) |
95.48% | Details | |
| 8/18/2021 | Organon & Co. | OGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2021 | Horizon Therapeutics | HZNP | New Coverage | Buy (N/A) |
88.59 (116.30) |
31.28% | Details | |
| 3/2/2021 | Bausch Health Companies | BHC | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2020 | Horizon Therapeutics | HZNP | New Coverage | Buy (N/A) |
73.07 (116.30) |
59.16% | Details |
